Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma.

Failure to meet established HNSCC treatment metrics generates significant, yet avoidable, institutional financial toxicity which is particularly relevant to integrated single-payer systems such as the VHA in the modern immunotherapy era.